Akero Therapeutics, Inc.
AKRODelisted Dec 9, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001744659
Akero Therapeutics, Inc. was delisted on Dec 9, 2025; its insiders filed their last Form 4 on Dec 9, 2025; 265 institutions reported holding it in 13F filings for Q3 2025, worth $4.34B in total; no superinvestor held it.
Q2 2022 vs. Q1 2022
How the institutions holding Akero Therapeutics, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Of which not filed for Q2 2022 | Q2 2022 | Change |
|---|---|---|---|---|
| Holders | 103 | 2 | 113 | +12 |
| Shares | 35.2M | 39.3K | 36.7M | +1.57M (+4.5%) |
| Value | $499.2M | $558.0K | $329.6M | −$169.0M (−33.9%) |
2 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (22)
Institutions that held Akero Therapeutics, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Marshall Wace, LLP | 1,005,682 | $9.50M | 0.02% |
| Long Focus Capital Management, LLC | 290,000 | $2.74M | 0.55% |
| Silverarc Capital Management, LLC | 260,325 | $2.46M | 1.15% |
| Bank of Montreal | 69,653 | $769.0K | 0.00% |
| PDT Partners, LLC | 38,872 | $367.0K | 0.03% |
| Occudo Quantitative Strategies LP | 31,915 | $302.0K | 0.02% |
| Connor, Clark & Lunn Investment Management Ltd. | 31,091 | $294.0K | 0.00% |
| Engineers Gate Manager LP | 28,899 | $273.0K | 0.01% |
| Dynamic Technology Lab Private Ltd | 28,155 | $266.0K | 0.03% |
| Schonfeld Strategic Advisors LLC | 23,900 | $225.0K | 0.00% |
| SG Americas Securities, LLC | 21,415 | $202.0K | 0.00% |
| Ergoteles LLC | 19,300 | $182.0K | 0.01% |
| XTX Topco Ltd | 13,305 | $126.0K | 0.05% |
| HSBC Holdings PLC | 13,064 | $124.0K | 0.00% |
| D. E. Shaw & Co., Inc. | 10,670 | $101.0K | 0.00% |
| Parallel Advisors, LLC | 3,917 | $37.0K | 0.00% |
| FMR LLC | 582 | $5.00K | 0.00% |
| Quadrant Capital Group LLC | 557 | $5.00K | 0.00% |
| Crewe Advisors LLC | 242 | $2.00K | 0.00% |
| Captrust Financial Advisors | 53 | $1.00K | 0.00% |
| Lindbrook Capital, LLC | 132 | $1.00K | 0.00% |
| CoreCap Advisors, LLC | 50 | $0 | 0.00% |
Sold out (10)
Institutions that held Akero Therapeutics, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Versant Venture Management, LLC | 617,727 | $8.77M |
| Rafferty Asset Management, LLC | 67,455 | $957.0K |
| Susquehanna International Group, LLP | 27,553 | $391.0K |
| DekaBank Deutsche Girozentrale | 13,500 | $197.0K |
| Invesco Ltd. | 10,585 | $150.0K |
| ACT Capital Management, LLC | 10,000 | $142.0K |
| State of Wyoming | 628 | $9.00K |
| Bessemer Group Inc | 203 | $3.00K |
| Kayne Anderson Rudnick Investment Management LLC | 89 | $1.00K |
| Fortitude Advisory Group L.L.C. | 71 | $1.00K |
Not filed for Q2 2022 yet (2)
Institutions that held Akero Therapeutics, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Teachers Retirement System of the State of Kentucky | 35,353 | $502.0K |
| Amalgamated Financial Corp. | 3,919 | $56.0K |